Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
Mitochondrial dysfunction has been associated with various diseases, such as cancer, myopathies, neurodegeneration and obesity. Mitochondrial homoeostasis is achieved by mechanisms that adapt the number of mitochondria to that required for energy production and for the supply of metabolic intermedia...
Main Authors: | Marlous J. Groenewoud, Fried J. T. Zwartkruis |
---|---|
Format: | Article |
Language: | English |
Published: |
The Royal Society
2013-01-01
|
Series: | Open Biology |
Subjects: | |
Online Access: | https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.130185 |
Similar Items
-
Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling
by: Mostafizur Rahman, et al.
Published: (2024-01-01) -
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
by: Zongsheng Duan, et al.
Published: (2018-07-01) -
Recognition and Management of Oral Mucosal Injury Caused by Mammalian Target of Rapamycin Inhibitors: A Case Series
by: Timothy F. Meiller, et al.
Published: (2015-08-01) -
Leucine regulates α-amylase and trypsin synthesis in dairy calf pancreatic tissue in vitro via the mammalian target of rapamycin signalling pathway
by: L. Guo, et al.
Published: (2019-01-01) -
Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
by: Rita Leal, et al.
Published: (2018-03-01)